Long-acting insulin is safer, more effective for patients with Type 1 diabetes

Long-acting insulin is safer and more effective than intermediate-acting insulin for patients with Type 1 diabetes, according to new research.

Researchers looked at once-daily and twice-daily doses of both long- and intermediate-acting insulin, ranking their effectiveness, safety and cost-effectiveness.